SGD-1910

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

SGD-1910  纯度: 95.06%

SGD-1910 是抗体偶联药物的一部分 (drug-linker conjugate for ADC)，它由 PBD (一种细胞毒性 DNA 交联剂) 和可降解 (cleavable) 的 MC-Val-Ala 连接而成。

SGD-1910

SGD-1910 Chemical Structure

CAS No. : 1342820-51-2

规格 价格 是否有货 数量
1 mg ￥9500 In-stock
5 mg ￥28000 In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

生物活性

SGD-1910 is a drug-linker conjugate for ADC by using the antitumor antibiotic, pyrrolobenzodiazepine (PBD, a cytotoxic DNA crosslinking), linked via the cleavable linker MC-Val-Ala[1].

IC50 & Target[1]

Pyrrolobenzodiazepines

 

体外研究
(In Vitro)

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

1089.20

Formula

C60H64N8O12
CAS 号

1342820-51-2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献

  • [1]. John A Hartley. Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy. Expert Opin Biol Ther. 2020 Jun 16;1-13.

    [2]. Jeffrey SC, et al. A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology. Bioconjug Chem. 2013 Jul 17;24(7):1256-63.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务